Showing posts with label LARCs. Show all posts
Showing posts with label LARCs. Show all posts

Friday, November 27, 2015

Current Contraceptive Use and Variation by Selected Characteristics Among Women Aged 15–44: United States, 2011–2013

Objective
This report describes current contraceptive use among women of childbearing age (ages 15–44) during 2011–2013. Current contraceptive use is defined as use during the month of interview, not for a specific act of sexual intercourse. This report’s primary focus is describing patterns of contraceptive use among women who are currently using contraception, by social and demographic characteristics. Data from 2002 and 2006–2010 are presented for comparison.

Methods
Data for the 2011–2013 National Survey of Family Growth (NSFG) were collected through in-person interviews in respondents’ homes. The 2011–2013 NSFG, a nationally representative survey conducted by the Centers for Disease Control and Prevention’s National Center for Health Statistics, was based on interviews with 10,416 women and men aged 15–44 in the U.S. household population. This report is based on the sample of 5,601 women interviewed in 2011–2013, with a response rate of 73.4%.

Results
Among women currently using contraception, the most commonly used methods were the pill (25.9%, or 9.7 million women), female sterilization (25.1%, or 9.4 million women), the male condom (15.3%, or 5.8 million women), and long-acting reversible contraception (LARC)—intrauterine devices or contraceptive implants (11.6%, or 4.4 million women). Differences in method use were seen across social and demographic characteristics. Comparisons between time points reveal some differences, such as higher use of LARC in 2011–2013 compared with earlier time points.





Tuesday, November 24, 2015

Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand

Purpose
To describe changes in receipt of immediate postabortion long-acting reversible contraception (LARC) by adolescent and nulliparous women in New Zealand.

Methods
Nationally collected data on immediate postabortion receipt of an intrauterine method (intrauterine device [IUD]/intrauterine system [IUS]) or contraceptive implant were analyzed to describe proportions and demographic characteristics of women receiving LARC between 2007 and 2013. Changes in uptake over time were presented for adolescent, nulliparous, and parous women.

Results
Postabortion LARC uptake increased between 2007 and 2013, rising from 7.9% to 42.7% for adolescents and from 8.8% to 36.9% for nulliparous women. The increase was highest among nulliparous adolescents with a seven-fold increase in LARC uptake between 2007 and 2013. Adolescents had a five-fold increase and nulliparous women (of all ages) a four-fold increase. In 2013, IUD/IUS use was lowest among adolescents (22.4%) and increased with increasing age (43% by ages 40+ years), whereas implant use was highest among adolescents (20.3%) and decreased with increasing age (to 4.6% by age 40+ years). Nulliparous women had the lowest use of both IUD/IUS and implants in 2013, with 24.6% receiving an intrauterine method (compared with 43.2% for para 3+), and 12.3% an implant (compared with 17.5% for para 3+).

Conclusions
Despite an overall trend toward increased uptake of postabortion LARC by adolescent and nulliparous women, uptake in these groups still lags behind that of parous and older women. Reasons for differential uptake need to be explored and addressed if necessary to ensure all women have equitable access to the most effective methods of contraception.

Purchase full article at:  http://goo.gl/wQFU7Z

By:  Sally B. Rose, Ph.D., Susan M. Garrett, M.P.H.
Department of Primary Health Care and General Practice, University of Otago, Wellington, Wellington South, New Zealand
Correspondence
Address correspondence to: Sally B. Rose, Ph.D., Department of Primary Health Care and General Practice, University of Otago, Wellington, PO Box 7343, Wellington South 6242, New Zealand.
 


Saturday, November 14, 2015

Contraception for Adolescents After Abortion

Preventing repeated unplanned pregnancy among adolescents is still a challenge because many of them fail to use effective contraception after abortion. 

To review currently recommended options of methods and counselling for effective prevention of repeat pregnancies in adolescents. Methods Review of the literature that was identified through the Medline, ScienceDirect, Google and Popline databases and relevant expert opinions. 

Counselling needs to be adapted to the needs, values and lifestyle of adolescents. The best results are achieved with nondirective or active contraceptive counselling, followed by regular check-ups and cautious and attentive approach in the management of doubts, prejudices and side effects related to the contraceptive chosen. Adolescents should initiate contraception immediately after abortion: the motivation for choosing an efficacious method is highest at that time; resumption of ovulation following induced abortion occurs on average after three weeks; more than half of these girls will resume sexual activity within two weeks after pregnancy termination. Long-acting reversible contraception use during adolescence is safe and most effective. However, achieving a high long-term continuation rate is especially challenging in adolescents; this is due to developmental and environmental characteristics that influence their contraceptive behaviour. 

Adolescents should immediately after abortion initiate a reliable contraceptive method, preferably one whose efficacy is not user-dependent. Providing an appropriate health care would contribute to achieving continuity in the prevention of repeat pregnancy.

Purchase full article at:   http://goo.gl/pOh2dN

  • 1 Institute for Mother and Child Health Care of Serbia, Republic Family Planning Centre , Belgrade , Serbia.


Tuesday, November 10, 2015

Women’s Awareness of Their Contraceptive Benefits Under the Patient Protection and Affordable Care Act

The Patient Protection and Affordable Care Act mandates that there be no out-of-pocket cost for Food and Drug Administration–approved contraceptive methods. Among 987 privately insured reproductive aged Pennsylvania women, fewer than 5% were aware that their insurance covered tubal sterilization, and only 11% were aware that they had full coverage for an intrauterine device. For the Affordable Care Act contraceptive coverage mandate to affect effective contraception use and reduce unintended pregnancies, public awareness of the expanded benefits is essential.

Half of the pregnancies in the United States are unintended. Cost is a barrier to contraceptive use; in fact, when contraception is provided at no cost, women choose more effective and more expensive methods, such as long-acting reversible contraceptives (LARCs)—which include intrauterine devices (IUDs) and contraceptive implants—and have fewer unintended pregnancies. The Patient Protection and Affordable Care Act (ACA; Pub L No. 111–148) eliminates the cost barrier to contraception for most women with private health insurance by mandating coverage without patient cost sharing for Food and Drug Administration–approved contraceptive methods and tubal sterilization. Although this contraceptive coverage requirement went into effect in August 2012, whether privately insured women are aware of their newly expanded contraceptive benefits is unknown.

...Privately insured women are largely unaware of their contraceptive benefits under the ACA, and a substantial proportion would switch methods if there were no cost barrier. It is unclear whether the high proportion of women reporting “I don’t know” about coverage reflects a lack of method awareness or a lack of knowledge about coverage, which is a study limitation.

Before the ACA, studies suggested that full contraceptive coverage could increase use of LARCs and reduce unintended pregnancies and abortions. In 2002, the Kaiser Foundation Health Plan in California sent quarterly outreach publications to inform enrollees of their policy change to include 100% coverage of injectables and LARCs, resulting in a significant increase in the use of these methods. In the CHOICE project, women in the St. Louis, Missouri, region received dedicated counseling promoting LARCs and were provided no-cost contraception, resulting in a high uptake of LARCs and a reduction in unintended pregnancy. These demonstrations suggest that the ACA mandate may not lead to more effective contraceptive method use without efforts to inform both women and health care providers of the coverage mandate and to provide accurate information about method options. Furthermore, it is not clear whether insurers are complying with the mandate or if there is an adequate workforce to provide LARCs. Although system-level barriers to female sterilization under Medicaid regulations are well recognized, low awareness of coverage for sterilization may prove to be a barrier even among privately insured women.

For the ACA contraceptive coverage mandate to affect the use of effective contraception, raising women’s awareness of the expanded benefit is an essential first step. Private insurers, health care providers, and policymakers must do a better job of communicating the benefit, or this could be a missed opportunity to reduce unintended pregnancies and abortions among US women.

Below:  Awareness of contraceptive coverage based on the question, “To the best of your knowledge, does your health insurance policy currently cover these birth control methods at no cost to you (no copay or deductible payment)?”: Pennsylvania, 2014. Note. IUD = intrauterine device. The sample size was n = 987.



Full article at:  http://goo.gl/QT25sl

Cynthia H. Chuang is with the Division of General Internal Medicine, Penn State College of Medicine, Hershey, PA. Julie L. Mitchell is with the Department of Medicine, Penn State College of Medicine. Diana L. Velott, Erik B. Lehman, Lindsay Confer, and Carol S. Weisman are with the Department of Public Health Sciences, Penn State College of Medicine. Richard S. Legro is with the Department of Obstetrics and Gynecology, Penn State College of Medicine.
corresponding authorCorresponding author.
Correspondence should be sent to Cynthia H. Chuang, MD, MSc, 500 University Drive, HO34, Division of General Internal Medicine, Penn State Hershey, Hershey, PA 17033 (e-mail: ude.usp.cmh@gnauhcc). Reprints can be ordered at http://www.ajph.org by clicking the “Reprints” link.
Contributors
C. H. Chuang was the principal investigator for the MyNewOptions study; she conceptualized the study and wrote the article. J. L. Mitchell, D. L. Velott, R. S. Legro, E. B. Lehman, L. Confer, and C. S. Weisman contributed to data interpretation and to writing the article. E. B. Lehman analyzed the data.
 


Saturday, October 31, 2015

Long-Acting Reversible Contraceptives for Incarcerated Women: Feasibility and Safety of On-Site Provision

Many incarcerated women have an unmet need for contraception. Providing access to long-acting reversible contraceptive (LARC) methods-IUDs and implants-before release is one strategy to meet this need and potentially prepare them for reentry to the community, but the safety and feasibility of providing these methods in this setting have not been described.

A retrospective descriptive study of all LARC insertions at the San Francisco County Jail in 2009-2014 was conducted. Data from community clinic and jail clinic databases were assessed to examine baseline characteristics of LARC initiators, complications from insertion, method continuation, and pregnancy and reincarceration rates. Correlates of method discontinuation were assessed in multivariate logistic regression analyses.

Eighty-seven LARC devices were inserted during the study period-53 IUDs and 34 implants. There were no cases of pelvic inflammatory disease or other insertion complications in IUD users and no serious complications in implant users. Median duration of known use was 11.4 months for IUDs and 12.9 months for implants. Women who discontinued a LARC method most commonly cited a desire to get pregnant (32%). Black women were more likely than whites to discontinue use (odds ratio, 4.4).

It is safe and feasible to provide LARC methods to incarcerated women. Correctional facilities should consider increasing access to all available contraceptives, including LARC methods, in a noncoercive manner as a strategy to reduce reproductive health disparities among marginalized women at high risk of unplanned pregnancies.

Purchase full article at: http://goo.gl/8ckIhv

  • 1Assistant professor, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore. carolynsufrin@gmail.com.
  • 2Student at the School of Medicine, University of California, San Francisco.
  • 3Director, Jail Health Services, San Francisco Department of Public Health.
  • 4Assistant director of program management, Bixby Center for Global Reproductive Health and Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.
  • 5Assistant professor, Bixby Center for Global Reproductive Health and Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.  


Tuesday, September 29, 2015

Task Shifting Provision of Contraceptive Implants to Community Health Extension Workers: Results of Operations Research in Northern Nigeria

Contraceptive use remains low in Nigeria, with only 11% of women reporting use of any modern method. Access to long-acting reversible contraceptives (LARCs) is constrained by a severe shortage of human resources. To assess feasibility of task shifting provision of implants, we trained community health extension workers (CHEWs) to insert and remove contraceptive implants in rural communities of Bauchi and Sokoto states in northern Nigeria.

We conducted 2- to 3-week training sessions for 166 selected CHEWs from 82 facilities in Sokoto state (September 2013) and 84 health facilities in Bauchi state (December 2013). To assess feasibility of the task shifting approach, we conducted operations research using a pretest–posttest design using multiple sources of information, including surveys with 151 trained CHEWs (9% were lost to follow-up) and with 150 family planning clients; facility observations using supply checklists (N = 149); direct observation of counseling provided by CHEWs (N = 144) and of their clinical (N = 113) skills; as well as a review of service statistics (N = 151 health facilities). The endline assessment was conducted 6 months after the training in each state.

CHEWs inserted a total of 3,588 implants in 151 health facilities over a period of 6 months, generating 10,088 couple-years of protection (CYP). After practicing on anatomic arm models, most CHEWs achieved competency in implant insertions after insertions with 4–5 actual clients. Clinical observations revealed that CHEWs performed implant insertion tasks correctly 90% of the time or more for nearly all checklist items. The amount of information that CHEWs provided clients increased between baseline and endline, and over 95% of surveyed clients reported being satisfied with CHEWs’ services in both surveys. The study found that supervisors not only observed and corrected insertion skills, as needed, during supervisory visits but also encouraged CHEWs to conduct more community mobilization to generate client demand, thereby promoting access to quality services. CHEWs identified a lack of demand in the communities as the major barrier for providing services.

With adequate training and supportive supervision, CHEWs in northern Nigeria can provide high-quality implant insertion services. If more CHEWs are trained to provide implants and greater community outreach is conducted to generate demand, uptake of LARCs in Nigeria may increase.

Below: A family planning client from Bauchi state receives counseling on Jadelle implants by a Community Health Extension Worker (CHEW). Observation of counseling sessions confirmed that CHEWs provided accurate and complete information.



Below: A Community Health Extension Worker (CHEW) at Dorowa Dispensary, Dambam LGA, in Bauchi state, practices inserting contraceptive implants on an arm model. After achieving competency on the arm model, CHEWs inserted implants under supervision on actual clients.



Below: A male Community Health Extension Worker (CHEW) from Muzuwa Dispensary, Dambam LGA, in Bauchi state, inserts a contraceptive implant. Over 40% of the CHEWs in the pilot task shifting study were men, revealing the acceptance of male providers by women to deliver implant services.



Full article at: http://ht.ly/SONpK 


a​Palladium, Washington, DC, USA
b​Targeted States High Impact Project (TSHIP), Bauchi, Nigeria
c​JSI Research & Training Institute, Arlington, VA, USA
d​Jhpiego – an affiliate of Johns Hopkins University, Abuja, Nigeria